NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Navidea Biopharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2023.
  • Navidea Biopharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 100M shares, a 211% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 100M +67.9M +211% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 96.1M +65.8M +217% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 32.9M +2.49M +8.22% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 32.7M +2.41M +7.95% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 32.2M +1.99M +6.59% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 30.4M +219K +0.73% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 30.4M +1.65M +5.75% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 30.3M +3.13M +11.5% Dec 31, 2021 10-K 2023-03-27
Q3 2021 30.2M +3.79M +14.4% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 30.1M +5.6M +22.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 28.7M +7.51M +35.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 27.1M +7.91M +41.1% Dec 31, 2020 10-K 2022-03-28
Q3 2020 26.4M +8.31M +46% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 24.5M +6.49M +35.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 21.2M +11.1M +111% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 19.2M +9.22M +92% Dec 31, 2019 10-K 2021-03-26
Q3 2019 18.1M -164M -90.1% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 18.1M -146M -89% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 10.1M -153M -93.8% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 10M -152M -93.8% Dec 31, 2018 10-K 2020-03-18
Q3 2018 182M +19.7M +12.1% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 164M +1.41M +0.87% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 163M +1.06M +0.66% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 162M +6.44M +4.14% Dec 31, 2017 10-K 2019-03-15
Q3 2017 162M +6.46M +4.15% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 162M +6.57M +4.22% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 162M +6.39M +4.11% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 156M +113K +0.07% Dec 31, 2016 10-K 2018-03-15
Q3 2016 156M +5.05M +3.35% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 156M +4.93M +3.27% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 156M +4.89M +3.25% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 156M +5.45M +3.63% Dec 31, 2015 8-K 2017-12-15
Q3 2015 151M -31.9K -0.02% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 151M +75.7K +0.05% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 151M +773K +0.52% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 150M +14.3M +10.5% Dec 31, 2014 10-K 2016-03-23
Q3 2014 151M +16.4M +12.2% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 151M Jun 30, 2014 10-Q 2014-08-11
Q1 2014 150M +32.3M +27.5% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 136M +22.9M +20.3% Dec 31, 2013 10-K 2015-03-16
Q3 2013 134M +27M +25.1% Sep 30, 2013 10-Q 2013-11-12
Q1 2013 117M +21.3M +22.2% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 113M +17.6M +18.5% Dec 31, 2012 10-K 2014-03-14
Q3 2012 107M +12.3M +12.9% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 96.8M +2.27M +2.4% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 96.2M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 95.4M +9.08M +10.5% Dec 31, 2011 10-K/A 2013-03-21
Q3 2011 95.1M Sep 30, 2011 10-Q 2012-11-13
Q2 2011 94.5M Jun 30, 2011 10-Q 2012-08-09
Q4 2010 86.3M Dec 31, 2010 10-K 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.